Get Started

PFD

NYSE Flaherty & Crumrine Preferred and Income Fund Incorporated
Oct 30, 2026 · 9:18 AM ET LAST TRADE Market Closed

$0.0000 ↓ -10.5000 (-100.00%) Trading Down from the previous close of $10.5000

YTD change
N/A
vs 20-day SMA
N/A
vs 200-day SMA
N/A

Price ranges

Previous day
$10.38 $10.51
open $10.38 close $10.50
+$0.12 (+1.16%)
Today
$0.0000 $0.0000
$0.0000
Past week
$10.3100 $10.5100
from $10.4800 now $0.0000
-$10.4800 (-100.00%)
Past month
$10.3100 $10.8500
from $10.7500 now $0.0000
-$10.7500 (-100.00%)
This year
$10.3100 $12.1000
from $11.8700 now $0.0000
-$11.8700 (-100.00%)

Price & Performance

-1.16 (-9.95%) / 6M

$10.22$10.75$11.28$11.82Apr 30Jul 31Oct 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $20.8800
  • PFD is down 100% since the beginning of the year
  • PFD is down 100% over the past 12 months
  • PFD is down 100% over the past 1 month

PFD reads poor: the 12-month move is -11.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.273973
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Finance and Insurance
Sub Sector Funds, Trusts, and Other Financial Vehicles
Market cap N/A

Competitor comparison

TickerCompany PriceChange
PGPHF Partners Group Holding AG $770.00 -0.11%
PHYS.U.CAT SPROTT PHYSICAL GOLD TRUST USD $30.39 -1.07%
NLY Annaly Capital Management, Inc. $18.47 +0.98%
CPAMF CapitaLand Integrated Commercial Trust $1.80 +2.86%
ARCC Ares Capital Corporation $19.12 +3.18%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.